Report cover image

Global Donepezil Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 190 Pages
SKU # APRC20278637

Description

Summary

According to APO Research, The global Donepezil market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Donepezil include Apotex, ARK PHA.LTD, Cipla, Dr Reddy's Laboratories, Hansoh Pharma, Jishengtang Pharma, Luoxin, Sun Pharmaceutical and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Donepezil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Donepezil, also provides the sales of main regions and countries. Of the upcoming market potential for Donepezil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Donepezil sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Donepezil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Donepezil sales, projected growth trends, production technology, application and end-user industry.

Donepezil Segment by Company

Apotex
ARK PHA.LTD
Cipla
Dr Reddy's Laboratories
Hansoh Pharma
Jishengtang Pharma
Luoxin
Sun Pharmaceutical
Pfizer
Sandoz
Teva
Eisai
Donepezil Segment by Type

5mg
10mg
23mg
Donepezil Segment by Application

Hospitals
Clinics
Drugstore
Donepezil Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Donepezil Market Size, 2020 VS 2024 VS 2031
1.3 Global Donepezil Market Size Estimates and Forecasts (2020-2031)
1.4 Global Donepezil Sales Estimates and Forecasts (2020-2031)
1.5 Global Donepezil Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Donepezil Market Dynamics
2.1 Donepezil Industry Trends
2.2 Donepezil Industry Drivers
2.3 Donepezil Industry Opportunities and Challenges
2.4 Donepezil Industry Restraints
3 Donepezil Market by Manufacturers
3.1 Global Donepezil Revenue by Manufacturers (2020-2025)
3.2 Global Donepezil Sales by Manufacturers (2020-2025)
3.3 Global Donepezil Average Sales Price by Manufacturers (2020-2025)
3.4 Global Donepezil Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Donepezil Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Donepezil Manufacturers, Product Type & Application
3.7 Global Donepezil Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Donepezil Market CR5 and HHI
3.8.2 Global Top 5 and 10 Donepezil Players Market Share by Revenue in 2024
3.8.3 2024 Donepezil Tier 1, Tier 2, and Tier 3
4 Donepezil Market by Type
4.1 Donepezil Type Introduction
4.1.1 5mg
4.1.2 10mg
4.1.3 23mg
4.2 Global Donepezil Sales by Type
4.2.1 Global Donepezil Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Donepezil Sales by Type (2020-2031)
4.2.3 Global Donepezil Sales Market Share by Type (2020-2031)
4.3 Global Donepezil Revenue by Type
4.3.1 Global Donepezil Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Donepezil Revenue by Type (2020-2031)
4.3.3 Global Donepezil Revenue Market Share by Type (2020-2031)
5 Donepezil Market by Application
5.1 Donepezil Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Drugstore
5.2 Global Donepezil Sales by Application
5.2.1 Global Donepezil Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Donepezil Sales by Application (2020-2031)
5.2.3 Global Donepezil Sales Market Share by Application (2020-2031)
5.3 Global Donepezil Revenue by Application
5.3.1 Global Donepezil Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Donepezil Revenue by Application (2020-2031)
5.3.3 Global Donepezil Revenue Market Share by Application (2020-2031)
6 Global Donepezil Sales by Region
6.1 Global Donepezil Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Donepezil Sales by Region (2020-2031)
6.2.1 Global Donepezil Sales by Region (2020-2025)
6.2.2 Global Donepezil Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Donepezil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Donepezil Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Donepezil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Donepezil Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Donepezil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Donepezil Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Donepezil Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Donepezil Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Donepezil Revenue by Region
7.1 Global Donepezil Revenue by Region
7.1.1 Global Donepezil Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Donepezil Revenue by Region (2020-2025)
7.1.3 Global Donepezil Revenue by Region (2026-2031)
7.1.4 Global Donepezil Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Donepezil Revenue (2020-2031)
7.2.2 North America Donepezil Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Donepezil Revenue (2020-2031)
7.3.2 Europe Donepezil Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Donepezil Revenue (2020-2031)
7.4.2 Asia-Pacific Donepezil Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Donepezil Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Donepezil Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Apotex
8.1.1 Apotex Comapny Information
8.1.2 Apotex Business Overview
8.1.3 Apotex Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Apotex Donepezil Product Portfolio
8.1.5 Apotex Recent Developments
8.2 ARK PHA.LTD
8.2.1 ARK PHA.LTD Comapny Information
8.2.2 ARK PHA.LTD Business Overview
8.2.3 ARK PHA.LTD Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 ARK PHA.LTD Donepezil Product Portfolio
8.2.5 ARK PHA.LTD Recent Developments
8.3 Cipla
8.3.1 Cipla Comapny Information
8.3.2 Cipla Business Overview
8.3.3 Cipla Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Cipla Donepezil Product Portfolio
8.3.5 Cipla Recent Developments
8.4 Dr Reddy's Laboratories
8.4.1 Dr Reddy's Laboratories Comapny Information
8.4.2 Dr Reddy's Laboratories Business Overview
8.4.3 Dr Reddy's Laboratories Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Dr Reddy's Laboratories Donepezil Product Portfolio
8.4.5 Dr Reddy's Laboratories Recent Developments
8.5 Hansoh Pharma
8.5.1 Hansoh Pharma Comapny Information
8.5.2 Hansoh Pharma Business Overview
8.5.3 Hansoh Pharma Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Hansoh Pharma Donepezil Product Portfolio
8.5.5 Hansoh Pharma Recent Developments
8.6 Jishengtang Pharma
8.6.1 Jishengtang Pharma Comapny Information
8.6.2 Jishengtang Pharma Business Overview
8.6.3 Jishengtang Pharma Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Jishengtang Pharma Donepezil Product Portfolio
8.6.5 Jishengtang Pharma Recent Developments
8.7 Luoxin
8.7.1 Luoxin Comapny Information
8.7.2 Luoxin Business Overview
8.7.3 Luoxin Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Luoxin Donepezil Product Portfolio
8.7.5 Luoxin Recent Developments
8.8 Sun Pharmaceutical
8.8.1 Sun Pharmaceutical Comapny Information
8.8.2 Sun Pharmaceutical Business Overview
8.8.3 Sun Pharmaceutical Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Sun Pharmaceutical Donepezil Product Portfolio
8.8.5 Sun Pharmaceutical Recent Developments
8.9 Pfizer
8.9.1 Pfizer Comapny Information
8.9.2 Pfizer Business Overview
8.9.3 Pfizer Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Pfizer Donepezil Product Portfolio
8.9.5 Pfizer Recent Developments
8.10 Sandoz
8.10.1 Sandoz Comapny Information
8.10.2 Sandoz Business Overview
8.10.3 Sandoz Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Sandoz Donepezil Product Portfolio
8.10.5 Sandoz Recent Developments
8.11 Teva
8.11.1 Teva Comapny Information
8.11.2 Teva Business Overview
8.11.3 Teva Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Teva Donepezil Product Portfolio
8.11.5 Teva Recent Developments
8.12 Eisai
8.12.1 Eisai Comapny Information
8.12.2 Eisai Business Overview
8.12.3 Eisai Donepezil Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Eisai Donepezil Product Portfolio
8.12.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Donepezil Value Chain Analysis
9.1.1 Donepezil Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Donepezil Production Mode & Process
9.2 Donepezil Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Donepezil Distributors
9.2.3 Donepezil Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.